App aims to keep IBD patients on track

NCT ID NCT05316584

Ongoing Disease control Sponsor: University of Maryland, Baltimore Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a digital health system that reminds people with inflammatory bowel disease (IBD) to take their medication and lets them report symptoms. About 123 adults starting a new oral or injectable treatment will use the system or get standard care for 12 months. The goal is to see if the app improves medication adherence, disease control, and reduces emergency visits.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CROHN DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Crohn disease inflammatory bowel disease ulcerative colitis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CROHN DISEASE INFLAMMATORY BOWEL DISEASES ULCERATIVE COLITIS

Contacts and locations

Show contact details

Locations

New York University

New York, New York, 10016, United States
University of Cincinnati College of Medicine

Cincinnati, Ohio, 45267, United States
University of Maryland School of Medicine

Baltimore, Maryland, 21201, United States
University of North Carolina at Chapel Hill

Chapel Hill, North Carolina, 27599-7080, United States
Vanderbilt University Medical Center

Nashville, Tennessee, 37212, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.